Two Stocks with Promising Prospects and One We Find Risky: Marcus & Millichap (MMI), Watts Water Technologies (WTS), and Medpace (MEDP).

Marcus & Millichap has a net cash position of $174.2 million, but its lackluster 1.3% annual revenue growth and poor free cash flow margin make it an unattractive investment. On the other hand, Watts Water Technologies has a net cash position of $260.2 million and has achieved 9.3% annual revenue growth over the last five years. Medpace has a net cash position of $141.4 million and is projected to experience 17.9% revenue growth over the next 12 months.